Moxifloxacin Solution/ Drops
Product Images NDC 65862-840

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 65862-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel 0.5% (3 mL) Container Label (Moxifloxacin Fig1)

Package Label-principal Display Panel 0.5% (3 mL) Container Label (Moxifloxacin Fig1)
This appears to be a product label for an ophthalmic solution, distributed by Aurobindo Pharma USA, Inc. It contains Woriforacin and is intended for topical use only. Each mL of the solution contains 5.45 mg of Woriforacin equivalent. The recommended storage temperature is between 2°C and 25°C. The label also includes code information and a dosage instructions insert.*
FDA Label Image

Package Label-principal Display Panel 0.5% (3 mL) Carton Label (Moxifloxacin Fig2)

Package Label-principal Display Panel 0.5% (3 mL) Carton Label (Moxifloxacin Fig2)
This appears to be a label of an ophthalmic solution of Moxifloxacin by Aurobindo Pharma USA Inc. The solution is sterile and has a pH value that has been adjusted with sodium hydroxide. The solution is equivalent to Modforacin 5 for the treatment of eye infections. The label has dosage information. The solution should be stored at a temperature between 2 and 25°Celsius. *
FDA Label Image

Chemical Structure (Moxifloxacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.